Randomized Phase IV Trial to Compare Cetuximab With Concomitant Radiation Therapy With Concomitant Mitomycin-C and 5-Fluorouracil With Radiation Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Trial Profile

Randomized Phase IV Trial to Compare Cetuximab With Concomitant Radiation Therapy With Concomitant Mitomycin-C and 5-Fluorouracil With Radiation Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil; Mitomycin
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Acronyms MITOCET
  • Most Recent Events

    • 24 May 2016 Status changed from recruiting to discontinued.
    • 20 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 25 Mar 2014 Planned initiation date changed from 1 Jan 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top